Article Details

Equities Analysts Issue Forecasts for Intra-Cellular Therapies, Inc.'s Q1 2022 Earnings (NASDAQ ...

Retrieved on: 2021-05-12 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Equities Analysts Issue Forecasts for Intra-Cellular Therapies, Inc.'s Q1 2022 Earnings (NASDAQ .... View article details on hiswai:

Excerpt

BlackRock Inc. now owns 6,158,133 shares of the biopharmaceutical company's stock valued at $208,946,000 after acquiring an additional 259,565 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up